Alpha tocotrienol quinone: Phase IIb started

Edison began a double-blind, placebo-controlled, U.S. Phase IIb trial to evaluate thrice-daily 5 and 15 mg/kg EPI-743 for 6 months in about 30 patients ages 1-12 years. The trial includes a 6-month ex...